Hexafluorenium bromide: current status and a review.
D000769:Anesthesia, Inhalation; D000818:Animals; D001986:Bronchial Spasm / Q000139:chemically induced; D002415:Cats; D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds / Q000037:antagonists & inhibitors; D004285:Dogs; D004357:Drug Synergism; D005449:Fluorenes / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D005449:Fluorenes; D000644:Quaternary Ammonium Compounds; D013390:Succinylcholine